Navigation Links
Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
Date:3/31/2008

The Company's cardiovascular medicine clinical trial program includes ONTARGET, PRoFESS, TRANSCEND and other studies involving more than 75,000 patients in more than 40 countries. These studies were designed to evaluate ways to reduce the risk of damaging events in the heart, brain and other organs due to cardiovascular disease and to uncover new treatment strategies that improve patient outcomes and care.

About Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2006, Boehringer Ingelheim posted net sales of US $13.3 billion (10.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com .

About Micardis(R) (telmisartan)

Telmisartan is marketed in the United States by Boehringer Ingelheim as MICARDIS(R) tablets. MICARDIS is indicated for the treatment of hypertension.

USE IN PREGNANCY

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, MICARDIS tablets should be discontinued as soon as possible (see WARNINGS,
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
2. Viatronix V3D-Colon Utilized in Another Landmark Study
3. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
4. Hospital Launches Landmark Emergency Medicine Project
5. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
6. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
(Date:1/15/2014)... Jan. 15, 2014 The Cadence Fitness & Health ... by the Medical Fitness Association, a non-profit organization assisting ... full potential. The Cadence Fitness & Health Center is ... and second in the Chicagoland area. "The ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... 31, 2011 The Procter & Gamble Company (NYSE: ... joined its U.S. Sustainability Expert Advisory Panel (SEAP). The new ... Senior Manager, Clinton Global Initiative Dr. Howard Frumkin – ... Washington Terry Tamminen – Former Secretary, California Environmental Protection ...
... May 31, 2011 HeartSine Technologies, Inc, a ... its system warranty period to an exclusive 10 years on ... Public Access Defibrillator (PAD) for the ... currently is the fastest growing AED. The life of its ...
Cached Medicine Technology:P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 2P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 3HeartSine® Increases AED System Warranty to Longest in the Industry 2
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... at the University of California, San Diego School of ... who have suffered a recent major loss are more ... adults. , The study is published in this month,s ... . , Because compassionate behaviors are associated with better ... offer insights into ways to improve the outcomes of ...
(Date:4/17/2014)... Rochelle, NY, April 17, 2014U.S. military personnel who ... plus impact" concussive traumatic brain injury (TBI) were ... evacuated for other medical reasons. Differences in measures ... depression 6-12 months after injury are reported in ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... multinational corporation headquartered in Japan and the world,s ... of Toray Water Technology Laboratory (TWTL) in Singapore ... technologies. Nanyang Technological University (NTU),s Nanyang Environment and ... choice partner for its research activities in Singapore. ...
... Association (AUA) Foundation announced that Jennifer Dodson, MD, of ... AUA Foundation/NIDDK/NCI Surgeon-Scientist Award, offered by the AUA Foundation, ... Diseases (NIDDK) and the National Cancer Institute (NCI). ... have received the Surgeon-Scientist Award since the program began ...
... June 25, 2009, TIME: ... 722 12th St, NW, EVENT: ... town meeting to explain opposition to health care reform , ... on the 44th anniversary of Medicare., ...
... National Business Group on Health Recognizes HealthyQuest Program for ... 24 Quest Diagnostics Incorporated (NYSE: DGX ... and services, announced today that the National Business Group ... for Healthy Lifestyles Platinum Award to the company for ...
... CORTLANDT MANOR, N.Y., June 24 Polymedco, Inc. ... PATHFAST immunoassay analyzer, manufactured by Mitsubishi Chemical Medience ... of care system utilizes a chemiluminescent technology combined ... that allows this system to report highly accurate ...
... 2009) For Professor Chad Mirkin, good things come ... meter in size. Yet, as director of Northwestern University,s ... is anything but small. A prolific inventor and entrepreneur, ... of medical diagnostics and patient point-of-care and to ignite ...
Cached Medicine News:Health News:Toray to establish water treatment R&D center at NTU in Singapore 2Health News:Toray to establish water treatment R&D center at NTU in Singapore 3Health News:National Physician Summit & Petition: 'Take Back Medicine' 6/25/09 2Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 2Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 3Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 4Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 5Health News:PATHFAST(R) Rapid Whole Blood Immunoassay Analyzer from Polymedco 2Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 2Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 3Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 4
ROB-NEL Catheters (100% Latex-Free)...
Urethral Red Rubber Catheters (Latex)...
ULTRAMER Foley Catheter...
Silicone-Coated Foley Catheter 2-Way...
Medicine Products: